About Enhancer

Enhancer ID: E_01_0470
Species: human
Position : chrX:123856883-123858883
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  29772677
Enhancer experiment: Western Blot,Co-Immunoprecipitation,Cell Cycle Analysis,Crystal Violet Assay,Cytotoxicity Assay,flow cytometry
Enhancer experiment description: Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs.

About TF

TF name : XIAP
TF experiment: Western Blot,Co-Immunoprecipitation,Cell Cycle Analysis,Crystal Violet Assay,Cytotoxicity Assay,flow cytometry
TF experiment description: Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs.

About Function

Enhancer function : Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Overall, these findings suggest that lambertianic acid enhances TRAIL-induced apoptosis via inhibition of XIAP/NF-?B in TRAIL resistant NSCLCs.

About SNP

SNP ID: --

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs